Clinical Trial Update: BTRX-246040 Study in Participants With Parkinson's Disease With Motor Fluctuations [Phase 2]

View source ↗

Summary

This document reports the completion and posting of results for BlackThorn Therapeutics' Phase 2 study of BTRX-246040 in Parkinson disease patients with motor f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BTRX-246040

Snippet

Sponsor: BlackThorn Therapeutics, Inc. | Conditions: Parkinson Disease, Motor Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-06-24